EGFR and glioblastoma: It has previously been shown that EGFR amplification gives a tumorigenic advantage in GBM (Humphrey et al, 1988; Muleris et al, 1994), a feature that we often found associated with stable double-minute extra-chromosomal elements on caryotypic analysis (data not shown) (Bigner et al, 1989).